Evin A, Economos G , Hugues D, Gilbert E, Gracia D, Poulain P, Mateus C, Collet E, Planchet-Barraud B, Colpaert A, Perceau-Chambard É, Calvel LY, Franck C, Mallet D, Baumstarck K, Salas S.Support Care Cancer. 2026 Jan 20;34(2):109
Filtrer
2026
Connaissances et opinions des patients atteints d’un cancer avancé concernant la loi française sur les directives anticipées : une étude transversale multicentrique.
Evin A, Economos G , Hugues D, Gilbert E, Gracia D, Poulain P, Mateus C, Collet E, Planchet-Barraud B, Colpaert A, Perceau-Chambard É, Calvel LY, Franck C, Mallet D, Baumstarck K, Salas S.Support Care Cancer. 2026 Jan 20;34(2):109
doi: 10.1007/s00520-026-10352-3.PMID : 41554986
2026
RegeNovar: A phase I/II study of ubamatamab plus carboplatin, paclitaxel, and bevacizumab as salvage therapy in ovarian cancer with poor response to first-line chemotherapy.
B You, C Lebreton, F Subtil, A Carrot, JS Frenel, L Bengrine-Lefevre, …
Journal of Clinical Oncology 44 (16_suppl), TPS5640-TPS5640
2026
Follow-up of outpatients taking oral anticancer drugs in the multidisciplinary community hospital ONCORAL care plan.
A Guillemin, F Tamouro, C Herledan, AG Ruiz-Caffin, N Crégut, …
Journal of Clinical Oncology 44 (16_suppl), 1507-1507
2026
Single-port robot-assisted vaginal natural orifice transluminal endoscopic surgery hysterectomy and bilateral adnexectomy with retroperitoneal sentinel lymph node dissection for endometrial cancer in a morbidly obese patient
Louise Monioda, Aslam Mansoorb,Celine Chauleur
doi.org/10.1016/j.ijgc.2026.104994
2026
Longitudinal kinetics of human epididymis protein 4 in recurrent advanced ovarian carcinoma treated with platinum-based chemotherapy: mathematical modeling and prognostic implications
PMID: 42542430 / DOI: 10.1016/j.ijgc.2026.104852
2026
Abstract CT051: From preclinical models to first-in-human evaluation of STC-1010 immunotherapy in unresectable advanced colorectal cancer
D Tosi, A Italiano, A Hollebecque, B You, P Cassier, F Sclafani, …
Cancer Research 86 (8_Supplement), CT051-CT051
2026
Differences in first-line chemosensitivity assessed by ELIMination rate constant K in advanced serous ovarian cancer: evidence from Western and Japanese Trials in a Gynecologic Cancer InterGroup meta-analysis
Pauline Corbaux 1, Benoit You 2, Iain McNeish 3, Stephen Welch 4, Anna V Tinker 5, Mansoor R Mirza 6, Kristina Lindemann 7, Tatsuo Kagimura 8, Isabelle L Ray-Coquard 9, Fabien Subtil 10, Julien Péron 11, Karen Carty 12, Caroline Kelly 12, Olivier Colomban 13, Eleni Karamouza 14, Adrian Cook 15, Xavier Paoletti 16, Rosalind M Glasspool 17, Nozomu Yanaihara 18
Affiliations Expand
PMID: 42425044 / DOI: 10.1016/j.ijgc.2026.104805
2026
Baseline value and longitudinal kinetics of circulating nucleosomes during neo-adjuvant chemotherapy in newly diagnosed ovarian cancer: Results from a GINECO/GINEGEPS study of the randomized phase II CHIVA trial
Pauline Corbaux 1, Olivier Colomban 2, Gaelle Lescuyer 3, Isabelle Ray-Coquard 4, Gaëtan De Rauglaudre 5, Florence Joly 6, Cyril Abdeddaim 7, Pierre Combe 8, Cyriac Blonz 9, Guillaume Bataillon 10, Jérôme Meunier 11, Jérôme Alexandre 12, Dominique Berton 13, Marie-Christine Kaminsky 14, Diana Bello Roufai 15, Alexandra Leary 16, Laurence Venat 17, Nadine Dohollou 18, Christophe Louvet 19, Coriolan Lebreton 20, Sophie Abadie-Lacourtoisie 21, Jean-Pierre Lotz 22, Laure Favier 23, Michel Fabbro 24, Nathalie Bonichon-Lamichhane 25, Jean-Emmanuel Kurtz 26, Philippe Follana 27, Eric Pujade-Lauraine 28, Lea Payen 3, Benoit You 29
PMID: 42385345 / PMCID: PMC13342990 / DOI: 10.1016/j.tranon.2026.102896
2026
31MO Comparing efficacy of avelumab+ methotrexate vs. methotrexate alone in low-risk gestational trophoblastic neoplasia: A national registry-based external control comparison
PA Bolze, O Febvey-Combes, E Heymes, M Nourredine, T Hajri, F Subtil, …
ESMO Rare Cancers 5
2026
Response to Correspondence on « Differences in first-line chemosensitivity assessed by KELIM in advanced serous ovarian cancer: evidence from Western and Japanese trials in a Gynecologic Cancer InterGroup (GCIG) Meta-analysis »
PMID: 42586898 / DOI: 10.1016/j.ijgc.2026.104866
2026
47P Fertility and pregnancy outcomes after treatment with avelumab (anti-PD-L1) for gestational trophoblastic tumors: the FERTILAVE study
A Msika, L Eiriksson, JP Lotz, T Hajri, M Massoud, F Joly Lobbedez, T De La Motte Rouge, C Lebreton, L Gladieff, P Follana, C Desauw, M Provansal Gross, J Massardier, P Descargues, E Fraison, P Rousset, M Devouassoux-Shisheboran, F Golfier, B You, PA Bolze
ESMO Rare Cancers
2026
Longitudinal kinetics of human epididymis protein 4 in recurrent advanced ovarian carcinoma treated with platinum-based chemotherapy: mathematical modeling and prognostic implications
PMID: 42542430 / DOI: 10.1016/j.ijgc.2026.104852
CICLY – Centre d’Innovation en Chirurgie de la région Lyonnaise
Institut de Cancérologie des Hospices Civils de Lyon
Liens utiles
Adresse
165 Chemin du Grand Revoyet
69310 Pierre-Bénite, France